{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:29:49Z","timestamp":1772890189859,"version":"3.50.1"},"reference-count":44,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Poznan University of Medical Sciences","doi-asserted-by":"publisher","award":["Student Research grant 223"],"award-info":[{"award-number":["Student Research grant 223"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polish National Centre of Science","award":["PRELUDIUM 12 grant 2016\/23\/N\/NZ5\/02573"],"award-info":[{"award-number":["PRELUDIUM 12 grant 2016\/23\/N\/NZ5\/02573"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is associated with chronic complications, which are the result of neurovascular changes. There is still a lack of universal biochemical markers of microvascular damage. The present study aimed to investigate whether selected inflammatory proteins are related to the prevalence of microvascular complications in adult T1DM patients. The following markers were determined in a group of 100 T1DM participants: epidermal growth factor (EGF), metalloproteinase 2 (MMP-2), growth\/differentiation factor 15 (GDF-15), and interleukin 29 (IL-29). Screening for microvascular complications, such as autonomic and peripheral neuropathy, diabetic kidney disease, and retinopathy, was conducted. The group was divided according to the occurrence of microvascular complications. At least one complication was required for the patient to be included in the microangiopathy group. The median EGF concentration in the microangiopathy group was higher than in the group without microangiopathy (p = 0.03). Increasing EGF concentration was a statistically significant predictor of the presence of microangiopathy in multivariate logistic regression analysis (p &lt; 0.0001). Additionally, a higher GDF-15 level was associated with diabetic kidney disease, peripheral neuropathy, and proliferative retinopathy vs. nonproliferative retinopathy. GDF-15 concentration correlated negatively with estimated glomerular filtration rate (eGFR) (r = \u22120.28; p = 0.02). To conclude, higher EGF concentration is an independent predictor of the presence of microvascular complications in T1DM patients. Besides the relation between GDF-15 and diabetic kidney disease, it may be also associated with peripheral neuropathy and retinopathy.<\/jats:p>","DOI":"10.3390\/jcm9010198","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T04:05:51Z","timestamp":1578888351000},"page":"198","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel Biochemical Markers of Neurovascular Complications in Type 1 Diabetes Patients"],"prefix":"10.3390","volume":"9","author":[{"given":"Bogusz","family":"Falkowski","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Diabetology, Mickiewicza 2, Poznan University of Medical Sciences, 60-834 Poznan, Poland"},{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Przybyszewskiego 49, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Rogowicz-Frontczak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Diabetology, Mickiewicza 2, Poznan University of Medical Sciences, 60-834 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Przybyszewskiego 49, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Krygier","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Przybyszewskiego 49, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Wrotkowska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Przybyszewskiego 49, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Uruska","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Diabetology, Mickiewicza 2, Poznan University of Medical Sciences, 60-834 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Araszkiewicz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Diabetology, Mickiewicza 2, Poznan University of Medical Sciences, 60-834 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ruchala","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Przybyszewskiego 49, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Zozulinska-Ziolkiewicz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Diabetology, Mickiewicza 2, Poznan University of Medical Sciences, 60-834 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, G., Yan, Y., Xu, N., Yin, D., and Hui, Y. (2019). Treatment of type 1 diabetes by regulatory T-cell infusion via regulating the expression of inflammatory cytokines. J. Cell Biochem.","DOI":"10.1002\/jcb.27875"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2337\/dc07-0162","article-title":"Matrix metalloproteinase-2 dysregulation in type 1 diabetes","volume":"30","author":"Thrailkill","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10753-013-9598-y","article-title":"Association between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complications","volume":"36","author":"Wegner","year":"2013","journal-title":"Inflammation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2174\/1570159X14666160225154536","article-title":"Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective","volume":"14","author":"Araszkiewicz","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yang, Q., Zhang, Y., Yin, H., and Lu, Y. (2019). Topical recombinant human epidermal growth factor for diabetic foot ulcers: A meta-analysis of randomized controlled clinical trials. Ann. Vasc. Surg.","DOI":"10.1016\/j.avsg.2019.05.041"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2017.07.013","article-title":"Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes","volume":"99","author":"Sochett","year":"2017","journal-title":"Cytokine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/1440-1681.13029","article-title":"EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy","volume":"46","author":"Ju","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/dc09-2174","article-title":"Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy","volume":"33","author":"Lajer","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/dc12-0180","article-title":"Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes","volume":"35","author":"Hellemons","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F1249","DOI":"10.1152\/ajprenal.00387.2013","article-title":"Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes","volume":"305","author":"Mazagova","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-015-0195-2","article-title":"Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: The EURODIAB Prospective Complications Study","volume":"14","author":"Peeters","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-lambda: Immune Functions at Barrier Surfaces and Beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"ref_15","first-page":"31","article-title":"Increased expression of interferon-lambda in minor salivary glands of patients with primary Sjogren\u2019s syndrome and its synergic effect with interferon-alpha on salivary gland epithelial cells","volume":"36","author":"Ha","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1620\/tjem.241.89","article-title":"Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies","volume":"241","author":"Chang","year":"2017","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/08916934.2015.1054028","article-title":"Interferons and systemic sclerosis: Correlation between interferon gamma and interferon-lambda 1 (IL-29)","volume":"48","author":"Dantas","year":"2015","journal-title":"Autoimmunity"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wolk, K., Witte, K., Witte, E., Raftery, M., Kokolakis, G., Philipp, S., Sch\u00f6nrich, G., Warszawska, K., Kirsch, S., and Pr\u00f6sch, S. (2013). IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci. Trans. Med., 5.","DOI":"10.1126\/scitranslmed.3006245"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cea.12809","article-title":"Raised interferon-beta, type 3 interferon and interferon-stimulated genes\u2014Evidence of innate immune activation in neutrophilic asthma","volume":"47","author":"Hilzendeger","year":"2017","journal-title":"Clin. Exp. Allergy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4161\/self.2.2.16939","article-title":"Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals","volume":"2","author":"Fedenko","year":"2011","journal-title":"Self"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018","volume":"41","author":"Association","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_22","unstructured":"Rosner, B. (2011). Fundamentals of Biostatistics, Brooks\/Cole. [7th ed.]."},{"key":"ref_23","unstructured":"ClinCalc.com (2020, January 06). Available online: https:\/\/clincalc.com\/stats\/samplesize.aspx."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Falkowski, B., Rogowicz-Frontczak, A., Grzelka, A., Uruska, A., Schlaffke, J., Araszkiewicz, A., and Zozulinska-Ziolkiewicz, D. (2018). Higher free triiodothyronine concentration is associated with lower prevalence of microangiopathic complications and better metabolic control in adult euthyroid people with type 1 diabetes. Endocrine, 458\u2013465.","DOI":"10.1007\/s12020-018-1582-8"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5603\/EP.a2018.0029","article-title":"Study on the relationship between the methylation of the MMP-9 gene promoter region and diabetic nephropathy","volume":"69","author":"Yang","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"ref_27","first-page":"35","article-title":"Genetic predictors associated with diabetic retinopathy in patients with diabetic foot","volume":"128","author":"Nehring","year":"2018","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2337\/dc20-S011","article-title":"11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020","volume":"43","author":"Association","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1464-5491.1992.tb01754.x","article-title":"Assessment of cardiovascular autonomic function: Age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses","volume":"9","author":"Ziegler","year":"1992","journal-title":"Diabetes Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5603\/EP.a2019.0011","article-title":"Is our treatment in type 1 diabetes mellitus (insulin therapy models, metabolic control) optimal for preventing cardiovascular autonomic neuropathy?","volume":"70","author":"Pawlinski","year":"2019","journal-title":"Endokrynol. Pol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.kint.2016.01.015","article-title":"Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes","volume":"89","author":"Betz","year":"2016","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e000461","DOI":"10.1136\/bmjdrc-2017-000461","article-title":"Biomarkers of tubulointerstitial damage and function in type 1 diabetes","volume":"5","author":"Gao","year":"2017","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2015040415","article-title":"Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney","volume":"27","author":"Chen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","first-page":"256","article-title":"Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy","volume":"45","author":"Perlman","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.29271\/jcpsp.2018.09.686","article-title":"Comparative Analysis of Serum Proangiogenic Biomarkers between those with and without Diabetic Retinopathy","volume":"28","author":"Malik","year":"2018","journal-title":"J. Coll. Physicians Surg."},{"key":"ref_36","first-page":"1906","article-title":"Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness","volume":"15","author":"Ozturk","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bjo.78.9.714","article-title":"Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy","volume":"78","author":"Patel","year":"1994","journal-title":"Br. J. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo.81.3.228","article-title":"Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management","volume":"81","author":"Boulton","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2004.04.012","article-title":"EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques","volume":"176","author":"Lamb","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_41","first-page":"1024","article-title":"Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus","volume":"73","author":"Shiau","year":"2006","journal-title":"Mt. Sinai J. Med."},{"key":"ref_42","first-page":"444","article-title":"Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy","volume":"20","author":"Rysz","year":"2007","journal-title":"J. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/aoms.2010.14258","article-title":"Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy","volume":"6","author":"Klysik","year":"2010","journal-title":"Arch. Med. Sci."},{"key":"ref_44","first-page":"762","article-title":"Matrix metalloproteinases as drug targets in ischemia\/reperfusion injury","volume":"16","author":"Dejonckheere","year":"2011","journal-title":"Drug Discov. Today"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/1\/198\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:19:28Z","timestamp":1760361568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/1\/198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["jcm9010198"],"URL":"https:\/\/doi.org\/10.3390\/jcm9010198","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}